SCHEMBL27595474

SCHEMBL27595474

Cc1cc(Cl)nc2c([C]=O)c[nH]c12

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25024454 0.78 LMNA (0.38) LMNAHTT
SCHEMBL30233803 0.78 LMNA (0.38) LMNAHTT
SCHEMBL27614371 0.73 LMNA (0.34) LMNAHTT
SCHEMBL30934584 0.72 KDM4E (0.38)
SCHEMBL25212351 0.72 KDM4E (0.38)
SCHEMBL2628953 0.71 KMO (0.35) LMNAHTTSMN1; SMN2
SCHEMBL25024456 0.70 ROCK2 (0.37) LMNAHTTSMN1; SMN2
SCHEMBL30234055 0.70 ROCK2 (0.37) LMNAHTTSMN1; SMN2
Potassium Ion SCHEMBL1763104 0.70 KMO (0.32) LMNASMN1; SMN2
SCHEMBL27563129 0.65 MAPT (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101229164-B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO 2013-01-02 CN disclosed
CN-100384423-C Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-04-30 CN disclosed
CN-100379421-C Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-04-09 CN disclosed
CN-1688311-A Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2005-10-26 CN disclosed
CN-1612763-A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2005-05-04 CN disclosed